TY - JOUR T1 - Statin-induced autoimmune myopathy: a case report JF - European Journal of Hospital Pharmacy JO - Eur J Hosp Pharm DO - 10.1136/ejhpharm-2019-002102 SP - ejhpharm-2019-002102 AU - Natalia Alzueta AU - Marta Marin AU - Marta Castresana AU - Ana Gascón AU - María Pío AU - María Jesús Iguzquiza Y1 - 2019/11/07 UR - http://ejhp.bmj.com/content/early/2019/11/07/ejhpharm-2019-002102.abstract N2 - Statins are widely used in the treatment of hypercholesterolemia. Muscle weakness and elevated creatine kinase (CK) are frequent side effects of statins with an incidence of about 15%. Statin-associated myopathy is more common in people who receive multiple drugs, the elderly or women but the mechanism underlying it is still unclear. These symptoms generally improve after drug discontinuation. However, there is a type of autoimmune mediated myopathy characterised by the persistence of muscle weakness and CK elevation after stopping statins. Herein, we discuss a case of autoimmune myopathy associated with statin exposure and responsive to immunossupresive drugs. The increased use of statins in recent years raises the importance of acquaintance with this disease in clinical practice. ER -